Q Scientific Consulting Limited (QSCL), located in Harrogate UK, was founded in 2008 from two existing consultancies, each with over 10 years of advisory experience. QSCL’s clients range from start-up virtual companies, members of FTSE250, to global professional services organisations.
Chris Collins BSc(Hons), CBiol, ERT. Director and Senior Consultant (view LinkedIn profile)
A recognized expert in inhalation safety evaluation. An established consultant with 3 decades international experience with previous scientific and contracting experience at 3 major international CROs. Two decades of experience in drug development as a member of project teams with CMC, device and clinical colleagues and experienced in pharmacokinetics and interfacing to early clinical, research governance and clinical ethics. Product areas include dry powder and metered dose inhalers, generics, mucoactives, bronchodilators and CNS products. Experienced author/reviewer of scientific reports and clinical trial application and regular attendee at UK, EU and FDA meetings.
David Brown DPhil Senior Consultant (view LinkedIn profile)
Over 30 years’ experience managing early stage projects from first GLP nonclinical study to First In Man with 24 years toxicology experience at a major international CRO, with 5 years as Principal Toxicologist. Experience gained in both UK and USA, with frequent visits to EU and Japanese clients. Offers a critical, professional approach to clients, with strategic advice and practical problem solving, coupled with experience in dealing with all major regulatory authorities. Principal activities include:
- Strategic input into development plans;
- Interaction with regulatory bodies to validate development plans with CROs;
- Drafting nonclinical regulatory documents, such as CTD Modules 2 and 4;
- Support in technical due diligence reviews.
Thomas Smith BSc(Hons), ERT. Senior Consultant (View LinkedIn profile)
An experienced general toxicologist and animal facility manager with 20 years’ experience in various CROs in the conduct, reporting and reviewing of nonclinical safety evaluation including carcinogenicity studies and biotechnology products. Able to offer strategic advice on nonclinical development planning and contracting, practical experience of day to day monitoring and problem solving. Substantial experience in reviewing scientific and expert reports, and writing nonclinical overviews and CTDs including generic drugs.
Viktoria McDonald BSc(Hons), ERT. Senior Consultant (View LinkedIn profile)
An experienced regulatory toxicologist specialising in inhalation, and then a Phase I Clinical Project Manager with experience of First in Man studies and on a Clinical Ethics Committee. Able to offer strategic advice on interfacing nonclinical development to First in Man based on over a decade of experience gained at two major CROs.
Your request answered within 24 hours